Your search returned 2 results.

Results
	1.	Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial. [electronic resource] by Quillien, Véronique Lavenu, Audrey Ducray, François Joly, Marie-Odile Chinot, Olivier Fina, Frédéric Sanson, Marc Carpentier, Catherine Karayan-Tapon, Lucie Rivet, Pierre Entz-Werle, Natacha Legrain, Michèle Zalcman, Emmanuèle Lechapt Levallet, Guenaelle Escande, Fabienne Ramirez, Carole Chiforeanu, Dan Vauleon, Elodie Figarella-Branger, Dominique Producer: 20180404 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients. [electronic resource] by Quillien, Véronique Lavenu, Audrey Ducray, François Meyronet, David Chinot, Olivier Fina, Frédéric Sanson, Marc Carpentier, Catherine Karayan-Tapon, Lucie Rivet, Pierre Entz-Werle, Natacha Legrain, Michèle Zalcman, Emmanuèle Lechapt Levallet, Guenaelle Escande, Fabienne Ramirez, Carole Chiforeanu, Dan Vauleon, Elodie Figarella-Branger, Dominique Producer: 20180718 In: Cancer biomarkers : section A of Disease markers vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search